Cost
$12,000 - $28,000
Procedure Type:
Minimally Invasive Procedure
Hospitalization Days:
1-3 days
Procedure Duration:
1-2 hrs
Success Rate:
70-95%
Liver cancer is one of the most challenging cancers to treat, especially when surgery is not an option. For such cases, Transarterial Radioembolization (TARE), also known as Selective Internal Radiation Therapy (SIRT), is one of the most advanced and precise treatment options available today. It delivers tiny radioactive beads directly into the liver tumor, allowing powerful radiation to target cancer from the inside while sparing healthy tissue.
India has become a leading global destination for TARE treatment due to its skilled interventional radiologists, FDA-approved radioactive microspheres, advanced imaging facilities, and affordable pricing structure. International patients choose India because they receive world-class cancer care at a significantly lower cost with seamless support services. The cost of Transarterial Radioembolization (TARE) in India ranges from USD 12,000 to USD 28,000 per session.
TARE is a minimally invasive procedure in which millions of microscopic radioactive beads (usually Yttrium-90 or Y-90) are delivered into the artery supplying the tumor. These beads emit radiation directly into cancer cells over several days.
TARE works through two combined actions:
Unlike external radiation therapy, TARE targets the tumor internally with high precision, causing minimal harm to surrounding liver tissue.
TARE techniques vary based on the type of radioactive microspheres used and how selectively they are delivered. Different materials and delivery methods allow doctors to customize treatment depending on tumor size and liver function.
These beads are made of resin and are commonly used for treating liver metastases and hepatocellular carcinoma (HCC). They release radiation gradually and have been widely used worldwide. Resin microspheres are effective for patients with large tumors and certain metastatic cancers.
Glass microspheres offer a higher radiation dose per bead, making them suitable for more aggressive tumors. They are used in cases where stronger localized radiation is required. Glass microspheres provide intense targeted therapy while preserving surrounding liver tissue.
Radiation is delivered to a very specific portion of the liver using micro-catheters. This technique allows high-dose radiation to a segment while keeping most of the liver untouched. This approach is ideal for patients with localized tumors and good liver function.
Advanced imaging and software calculate the exact radiation dose needed for each patient. This ensures precise targeting and improved treatment response. Personalized TARE enhances effectiveness and minimizes radiation-related side effects.
TARE is a preferred option for liver tumors that cannot be removed surgically or treated effectively with standard chemotherapy. TARE works best when the tumor still receives blood supply from the hepatic artery and liver function is reasonably preserved.
You may be a suitable candidate if:
A thorough evaluation helps identify the patients who will benefit most from TARE while ensuring safety.
TARE requires careful planning because each liver has different blood vessel anatomy. Diagnostics help doctors map blood flow and ensure radioactive beads reach only the tumor.
Common evaluations include:
These steps help tailor treatment, minimize risks, and determine the correct radiation dose.
TARE treatment packages in India simplify the cost structure and include most procedure-related expenses. They provide clarity for international patients planning multi-stage liver cancer treatment.
Typically included:
Not usually included:
Packages are designed to cover the essential phases of TARE while offering transparency for international patients.
India has become a leading hub for advanced liver cancer treatment, including radioembolization. Indian hospitals offer FDA-approved Y-90 TARE at an affordable cost while maintaining global treatment standards.
Key reasons patients choose India:
India combines world-class technology with affordability, making TARE accessible to patients worldwide.
International patients often require logistical and administrative support to begin treatment quickly. Indian hospitals provide coordinated services to make the process smooth and stress-free. Cancer care involves multiple appointments, so organized support helps patients stay comfortable and confident.
Hospitals help review insurance policies, prepare treatment documents, and support reimbursement processes when possible.
Patients receive visa invitation letters and step-by-step guidance on documentation and visa approval.
Hospitals assist with airport pickup, nearby accommodation arrangements, translation services, and follow-up scheduling.
These services simplify the entire treatment journey, helping patients focus on recovery and comfort.
The cost of TARE in India is influenced mainly by the type of Y-90 microsphere used and tumor complexity. TARE is more expensive than TACE because it involves specialized radioactive materials. The cost of Transarterial Radioembolization (TARE) in India ranges from USD 12,000 to USD 28,000 per session.
Cost variation by material:
Even with advanced radioactive materials, India offers TARE at far lower rates than most global cancer centers.
Transparent · Professional · Without Hassles
Book Doctor Appointment
Consult on Video or in-person at Hospital
Compare Cost Estimates
Hospitalisation Support
Costs vary depending on patient-specific and treatment-specific factors. The microsphere material is the largest component of the total treatment cost.
Cost-influencing factors include:
A personalized diagnostic assessment determines the precise cost for each patient.
TARE treatment is significantly more affordable in India without compromising safety or outcomes. India offers the same FDA-approved TARE devices used in Western countries, but at a substantially lower price.
| Country | TARE Cost (per session) |
| India | USD 12,000 - USD 28,000 |
| USA | USD 40,000 - USD 90,000 |
| UK | USD 35,000 - USD 70,000 |
| UAE | USD 28,000 - USD 60,000 |
| Singapore | USD 38,000 - USD 80,000 |
| Turkey | USD 18,000 - USD 35,000 |
India provides world-class radioembolization at one of the most competitive costs globally.
TARE is a step-by-step treatment that requires both mapping and final therapy sessions. It is a minimally invasive procedure that is performed through a small catheter inserted into the artery.
The structured two-step approach ensures precision, safety, and optimal radiation targeting.
Recovery after TARE is usually smooth, with symptoms improving steadily over days to weeks. Some fatigue or mild fever is common and usually temporary.
Adhering to aftercare plans ensures the best possible result and timely detection of any complications.
Reach out to us today for a free consultation and customized treatment plan.
Our services are FREE and by using our services your hospital bill does not increase!
TARE is minimally invasive and generally not painful. Some mild discomfort or fatigue may occur after the procedure.
Results are typically visible within 6-12 weeks during follow-up MRI or CT scans.
TARE is usually not curative but can significantly shrink tumors, control growth, and improve survival.
Most patients need only one session. In certain cases, a second session may be planned.
Yes, provided liver function and overall health are stable.
Fatigue, mild abdominal pain, nausea, and low-grade fever, all temporary and manageable.
Many international patients travel within 7-10 days after the procedure with the doctor's approval.
Yes, TARE is often used with systemic therapy, TACE, or as a bridge to liver transplant.
Your doctor may recommend another treatment, such as TACE, systemic therapy, or repeat TARE, depending on response.
No, the radiation effect is localized within the liver and poses no risk to family members.
